Medical Innovation Exchange

Rivus raises $132M series B as obesity, NASH prospects for metabolic drug heat up

https://www.fiercebiotech.com/biotech/rivus-raises-132m-series-b-drug-prospects-obesity-nash-heat

Leave a Comment

Your email address will not be published.

Leave the field below empty!